Allarity Therapeutics, Inc. Impairment of Intangible Assets, Finite-lived
Allarity Therapeutics, Inc. (ALLR) reported Impairment of Intangible Assets, Finite-lived of $17.57 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2024-03-08
- Allarity Therapeutics, Inc. impairment of intangible assets, finite-lived for the quarter ending 2022-12-31 was $3.56M.
- Allarity Therapeutics, Inc. impairment of intangible assets, finite-lived for the quarter ending 2022-09-30 was $0.00.
- Allarity Therapeutics, Inc. impairment of intangible assets, finite-lived for the quarter ending 2022-06-30 was $0.00.
- Allarity Therapeutics, Inc. impairment of intangible assets, finite-lived for the quarter ending 2022-03-31 was $14.01M.
- Allarity Therapeutics, Inc. impairment of intangible assets, finite-lived for fiscal 2022 was $17.57M.
- Allarity Therapeutics, Inc. impairment of intangible assets, finite-lived for fiscal 2021 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $3.56M derived: sum of 2 quarters · filed 2024-03-08 | $3.56M derived: sum of 3 quarters · filed 2024-03-08 | $17.57M 10-K · filed 2024-03-08 | $17.57K 10-K · filed 2023-03-13 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $14.01M 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $14.01M 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $14.01M 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |